반응식
[NH:1]1[CH2:6][CH2:5][CH2:4][C@H:3]([NH:7][C:8](=[O:14])[O:9][C:10]([CH3:13])([CH3:12])[CH3:11])[CH2:2]1.Cl[C:16]1[N:21]=[C:20](N2CCCCC2)[C:19]([N+:28]([O-])=O)=[CH:18][N:17]=1>>[NH2:28][C:19]1[C:18]([N:1]2[CH2:6][CH2:5][CH2:4][C@H:3]([NH:7][C:8](=[O:14])[O:9][C:10]([CH3:11])([CH3:13])[CH3:12])[CH2:2]2)=[N:17][CH:16]=[N:21][CH:20]=1참가 물질
3
실험 절차
Method 1 was followed using (S)-tert-butyl piperidin-3-ylcarbamate and 2-chloro-5-nitro-4-(piperidin-1-yl)pyrimidine. LCMS (m/z): 294.2 (MH+), Rt=0.56 min.
출처 및 근거
- ORD 기록
- ord-ceebac8809934efb809daf6f6f9825eb
- 출처 데이터셋
- uspto-grants-2014_06
- 특허 번호
- US08759338B2
연결된 노트
불러오는 중…